Provention bio appoints miguel sanjuan, ph.d. as senior vice president of research and early development

Red bank, n.j., nov. 5, 2021 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced the appointment of miguel sanjuan, ph.d.
PRVB Ratings Summary
PRVB Quant Ranking